When you’re dealing with preimplantation genetic testing PGT/PGD, navigating the emotional roller coaster of fertility treatments or carrying the heavy anxiety of a hereditary medical condition can feel completely overwhelming—which is why this technology is nothing short of a modern medical milestone.

Stripped of the complex lab jargon, it is a highly sophisticated technique that allows scientists to check the genetic health of an embryo during an In Vitro Fertilization (IVF) cycle before it ever reaches the uterus.

By screening for specific genetic mutations or chromosomal anomalies, fertility teams can select the healthiest embryos. For patients, this means drastically higher success rates, a lower chance of miscarriage, and the power to halt inherited diseases in their tracks.

Decoding the Alphabet Soup: PGD vs. PGS vs. PGT

If you’ve been researching this online, you’ve likely run into a confusing wall of shifting acronyms. The international reproductive medicine community updated the official terminology to make it clearer for patients and clinicians alike. Everything now falls under the umbrella term PGT, broken down into three distinct types depending on exactly what the scientists are looking for:

• The Old “PGD” has been split into PGT-M (diagnostic screening for specific single-gene mutations) and PGT-SR (screening for structural issues in chromosomes).
  
• The Old “PGS” is now known as PGT-A (a broader, preventative screening tool looking for random numerical chromosome errors).

Historical Term	Modern Acronym	The Simple Explanation	Who Is It For?
PGD	PGT-M (Monogenic)	Hunts for a single, specific inherited gene mutation.	Couples who know they are carriers of a specific genetic disease (e.g., Sickle Cell Anemia).
PGD	PGT-SR (Structural Rearrangements)	Checks for tangled, broken, or inverted chromosomes.	Individuals with known structural chromosomal variants or balanced translocations.
PGS	PGT-A (Aneuploidy)	Counts the total number of chromosomes to ensure there aren’t too many or too few.	Parents of advanced maternal age (35+), or those dealing with unexplained recurrent miscarriages.

Inside the Lab: How Preimplantation Genetic Testing PGT/PGD Actually Works

The PGT process is a beautifully synchronized sequence between your reproductive endocrinologist and a specialized embryology lab. Because it requires direct microscopic access to the embryo, it can only happen as part of a comprehensive IVF cycle.

1. Ovarian Stimulation & Retrieval: Days 1–12 of cycle.

The female partner takes hormone injections to encourage the ovaries to mature multiple eggs at once. Once ready, those eggs are retrieved during a brief, sedated outpatient procedure.

2. Fertilization via ICSI: Day of retrieval.

To make sure no stray paternal or maternal cellular debris interferes with the future genetic test, embryologists use Intracytoplasmic Sperm Injection (ICSI)—literally hand-selecting a single high-quality sperm and injecting it straight into the egg.

3. Growing to the Blastocyst Stage: Days 5–6 post-fertilization.

The fertilized eggs are tucked away in specialized incubators to grow for 5 to 6 days. The goal is to reach the blastocyst stage, where the embryo has split into two distinct parts: an inner cell mass (the future baby) and an outer layer called the trophectoderm (the future placenta).

4. The Microscopic Biopsy: Days 5–7.

Using an incredibly precise laser under a high-powered microscope, a senior embryologist gently snips away a tiny sample of 5 to 10 cells from that outer placenta layer. Crucially, the inner cells that actually form the baby are left completely undisturbed.

5. Flash Freezing (Vitrification): Immediate post-biopsy.

While the cell sample is safely shipped off to a specialized genetics lab for DNA sequencing, the embryos themselves are instantly frozen using vitrification. They stay perfectly preserved in liquid nitrogen without aging a single day.

6.The Report & Selective Transfer:10–14 days later.

The genetics lab uses Next-Generation Sequencing (NGS) to read the DNA. Once the report comes back identifying which embryos are genetically balanced (euploid), your clinical team prepares your body for a Frozen Embryo Transfer (FET), selecting the best candidate.

When Do Doctors Recommend PGT-M / PGD?

While PGT-A is often used as an optional tool to stack the odds of general IVF success in a patient’s favor, PGT-M (the classic PGD) is a targeted strike used when a couple has a known, serious genetic risk factor.

The primary clinical triggers include:

• Autosomal Dominant Conditions: If one parent carries a dominant mutation (like Huntington’s disease, Marfan syndrome, or the BRCA1/BRCA2 cancer genes), there is a 50% chance of passing it to their child. PGT-M can break that generational chain.
  
• Autosomal Recessive Conditions: Sometimes both parents are entirely healthy but discover through routine preconception screening that they are both silent carriers for the exact same condition—most notably Sickle Cell Anemia (SS), Cystic Fibrosis, or Spinal Muscular Atrophy. When this happens, there is a 25% risk with every single pregnancy of having an affected child.
  
• X-Linked Diseases: Conditions carried on the X chromosome (like Duchenne Muscular Dystrophy or Hemophilia) often hit male children the hardest.
  
• HLA Tissue Typing: A rare but profound application where an embryo is chosen because its tissue type matches an existing sick sibling who needs a life-saving bone marrow or stem cell transplant.

Reality Check: The Financial Cost of PGT

When looking at standalone laboratory genetic testing fees—completely separate from your core IVF expenses like ovarian stimulation medications, egg retrieval procedures, and frozen embryo transfers—the pricing models across specialized fertility centers generally depend on the depth of the analysis.

In high-end private clinics, comprehensive standalone PGT laboratory fees generally range from ₦800,000 to ₦1,500,000 for standard screenings, though specialized or all-inclusive batch testing packages can scale upward depending on the laboratory.

Why the Price of PGT Differs Safely Between Patients

The exact cost of your genetic protocol is rarely fixed, fluctuating primarily due to these distinct clinical elements:

• PGT-A vs. PGT-M Complexity: PGT-A counts chromosomes using standard panels that a laboratory can run regularly. PGT-M, however, requires hunting for a specific single-gene mutation unique to your family tree. Before your cycle even starts, the lab must build a custom molecular probe (a personalized genetic test design) specifically tailored to your DNA profile. This custom engineering drives up the price.
  
• Batch Pricing vs. Per-Embryo Fees: Many modern clinics bill via a flat rate covering up to a specific number of embryos (e.g., a batch of 4 to 6). Others charge a baseline fee for the physical biopsy procedure, plus a fixed fee for every individual blastocyst sent to the sequencer. If your cycle yields a high number of stable blastocysts, your final bill scales with it.
  
• Domestic vs. International Logistics: Running high-throughput NGS genetic testing requires highly specialized equipment. To maintain accuracy, many clinics biopsy and freeze the embryos locally, but securely ship the harvested cell samples to international genetic laboratories in Europe or the US for the actual sequencing. Foreign exchange fluctuations and international logistics play a major role in the ultimate price structure.
  
• Ancillary Lab Add-ons: To safely sample the cells, embryologists often need to perform Laser-Assisted Hatching (making a tiny opening in the embryo’s outer shell). Because sequencing takes up to two weeks, the embryos must be frozen via vitrification while you wait. Some clinics include hatching, freezing, and temporary storage in their flat rates, while others bill them as separate line items.

Accuracy, Success, and the “Fine Print”

With current Next-Generation Sequencing (NGS) technology, the diagnostic accuracy of PGT is exceptionally high, sitting right around 98% to 99%. But it is vital to treat it as an advanced screening mechanism rather than a flawless crystal ball.

Critical Nuances to Keep in Mind

• The Mosaicism Conundrum: Biology isn’t always uniform. Sometimes, an embryo is “mosaic,” meaning it contains a mixture of both normal and abnormal cells. Because a biopsy only takes a tiny sample from the outer layer (the future placenta), it might occasionally miss the true genetic picture of the inner cell mass (the baby).
  
• The Risk of Having Zero Embryos: For couples dealing with low ovarian reserve or a high genetic mutation load, there is a very real, heartbreaking risk that an entire IVF cycle might result in zero healthy embryos available for a safe transfer.
  
• The 1% Factor: While elite embryology labs have mastered this process, there is a tiny risk (less than 1%) that a fragile embryo might not survive either the microscopic biopsy or the subsequent freeze-thaw sequence.

A Note on Clinical Safety: Because nature loves a curveball, major medical authorities—including the American Society for Reproductive Medicine (ASRM)—strongly recommend that a successful PGT pregnancy still be followed up with standard prenatal screening (like NIPT or an amniocentesis) later on during the pregnancy just to verify the results.

Frequently Asked Questions